196 related articles for article (PubMed ID: 7942323)
1. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
[TBL] [Abstract][Full Text] [Related]
2. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
3. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
4. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
6. The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts.
Tobetto K; Yamamoto Y; Kataoka M; Ando T; Sugimoto K; Himeno M
Jpn J Pharmacol; 1997 Dec; 75(4):371-9. PubMed ID: 9469643
[TBL] [Abstract][Full Text] [Related]
7. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
Nakatsugi S; Sugimoto N; Furukawa M
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
[TBL] [Abstract][Full Text] [Related]
8. Antipyretic activity of tebufelone (NE-11740) in man.
Powell JH; Meredith MP; Vargas R; McMahon FG; Jain AK
Agents Actions Suppl; 1991; 32():45-9. PubMed ID: 2069096
[TBL] [Abstract][Full Text] [Related]
9. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
10. CP-66,248, a new anti-inflammatory agent, is a potent inhibitor of leukotriene B4 and prostanoid synthesis in human polymorphonuclear leucocytes in vitro.
Moilanen E; Alanko J; Asmawi MZ; Vapaatalo H
Eicosanoids; 1988; 1(1):35-9. PubMed ID: 2856170
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
Tordjman C; Sauveur F; Droual M; Briss S; Andre N; Bellot I; Deschamps C; Wierzbicki M
Arzneimittelforschung; 2003; 53(11):774-9. PubMed ID: 14677373
[TBL] [Abstract][Full Text] [Related]
14. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
16. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
17. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 5-lipoxygenase activity by the natural anti-inflammatory compound aethiopinone.
Benrezzouk R; Terencio MC; Ferrandiz ML; Hernandez-Perez M; Rabanal R; Alcaraz MJ
Inflamm Res; 2001 Feb; 50(2):96-101. PubMed ID: 11289660
[TBL] [Abstract][Full Text] [Related]
20. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
